Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
An impedance threshold device (ITD) is a small one-way valve that sits in the ventilation path during cardiopulmonary resuscitation (CPR). It restricts air from re-entering the chest while the chest wall recoils, which is intended to increase the negative pressure inside the chest and improve blood return to the heart. The best-known product is the ResQPOD. This page explains what the device is, what FDA documents say about it, and how a large trial and a guideline source have treated it.
This page describes products and general use; it is not medical advice.
Who uses it: emergency medical services and resuscitation teams. FDA’s approval summary describes the ResQCPR system, which includes the ResQPOD ITD 16, as a CPR adjunct for adult patients with non-traumatic cardiac arrest.
What is an impedance threshold device?
An ITD is a valve that impedes air from entering the patient’s chest when pressure inside the chest is below atmospheric pressure, while allowing positive-pressure ventilation and exhalation with minimal resistance. FDA’s summary of safety and effectiveness for the ResQPOD ITD 16 describes it in these terms. The stated purpose is to augment negative pressure inside the chest during the decompression phase of CPR, to enhance venous return to the heart and blood flow during CPR.
How the valve is built and what FDA describes
FDA describes the ResQPOD ITD 16 as a fist-sized mechanical valve system that fits between a ventilation source and a facemask or an advanced airway device, including an endotracheal tube. The ventilation source can be a bag-valve or demand-valve resuscitator, a rescuer’s mouth, or an automated ventilator, with or without supplemental oxygen. A safety check valve opens if negative pressure inside the chest becomes large, for example during a spontaneous breath. A timing assist light flashes 10 times per minute (version 2) as ventilation-rate guidance when an advanced airway is in place.
ITD versus ResQCPR system
The ITD and the system are not the same regulatory item. The table below lists the FDA records for the ResQPOD name, taken from FDA’s summary document and the openFDA 510(k) database.
| FDA record | Item | Applicant | Date | Key detail |
|---|---|---|---|---|
| 510(k) K022906 | ResQPOD Circulatory Enhancer | Cprx, LLC | Decision 2003-06-11 | Product code BWF |
| 510(k) K033401 | Modification to ResQPOD Circulatory Enhancer | Advanced Circulatory Systems, Inc. | Decision 2003-11-20 | Product code BWF |
| PMA P110024 | ResQCPR System: ResQPUMP active compression-decompression device plus ResQPOD ITD 16 | Advanced Circulatory Systems, Inc. | Approved 2015-03-06 | Generic name: combination compression/decompression manual chest pump with impedance respiratory valve; indicated as a CPR adjunct in adult non-traumatic cardiac arrest; no known contraindications |
The PMA approval is for the pair of devices used together, not for the ITD alone. In the openFDA classification database, product code BWF is named “Spirometer, Therapeutic (Incentive)”, class 2, regulation 868.5690; that is how the two 2003 records are filed.
Types and variants
FDA documents cover one ITD model, the ResQPOD ITD 16, and the combined ResQCPR system.
| Variant | What the FDA record says | Key difference |
|---|---|---|
| ResQPOD ITD 16 | Fist-sized valve between the ventilation source and the facemask or advanced airway (PMA P110024 summary) | The valve alone; 510(k) records exist from 2003 |
| ResQCPR System | ResQPUMP plus ResQPOD ITD 16 (PMA P110024 summary) | Used with active compression-decompression CPR; approved as a combination |
Specifications that matter
| Specification | Value stated by FDA |
|---|---|
| Resistance to ventilation and expiration | Less than 5 cm H2O |
| Safety check valve opening | Opens if negative pressure in the chest exceeds -16 cm H2O |
| Size | Fist-sized |
| Timing assist light (version 2) | Flashes 10 times per minute |
| Position in the circuit | Between the ventilation source and a facemask or advanced airway device |
Evidence and guideline position
These are dated documents, shown without an editorial verdict.
- ROC PRIMED trial (N Engl J Med, 2011). Aufderheide and colleagues randomised 8,718 out-of-hospital cardiac arrest patients to a sham ITD (4,345) or an active ITD (4,373) with standard CPR. Survival to discharge with modified Rankin score of 3 or less was 6.0% (260) with the sham and 5.8% (254) with the active device; risk difference -0.1 percentage points, 95% CI -1.1 to 0.8, P=0.71. The authors concluded that the ITD did not significantly improve survival with satisfactory function in patients receiving standard CPR. PubMed PMID 21879897.
- 2015 guideline cycle. The Heart and Stroke Foundation of Canada’s highlights of the 2015 Guidelines Update for CPR and ECC state that routine use of the ITD as an adjunct to conventional CPR is not recommended, and also note a randomised trial suggesting that the ITD plus active compression-decompression CPR was associated with improved neurologically intact survival in out-of-hospital cardiac arrest. This is a 2015 document; later guideline updates should be checked directly.
How to choose
The FDA summary ties the ResQCPR system to a defined indication: adult patients with non-traumatic cardiac arrest, as a CPR adjunct. Any decision to stock or use an ITD belongs with the responsible medical director and the manufacturer’s instructions for use, in light of current resuscitation guidelines.
Safe use and handling basics
- The device is designed to sit in the ventilation path, so ventilation with a bag, mouth or automated ventilator continues through it (FDA summary).
- The timing light is ventilation-rate guidance with an advanced airway, not a diagnostic reading.
- Training, use and maintenance follow the manufacturer’s instructions for use and local protocols.
Common mistakes
- Treating “FDA cleared” and “FDA approved” as interchangeable: the 2003 records are 510(k) clearances, while the 2015 record is a PMA approval of the combined system.
- Reading the 2015 PMA indication as covering the ITD with standard CPR alone; the PMA is for the ResQCPR system.
- Citing the guideline position without its date.
Frequently asked questions
Is an ITD the same as a ResQPOD?
No. ITD is the device category; ResQPOD is a brand of ITD. FDA’s documents describe the ResQPOD ITD 16 as a valve device that impedes air entering the chest during chest recoil.
Is the ITD FDA approved?
FDA lists two 2003 510(k) decisions for the ResQPOD Circulatory Enhancer, and approved PMA P110024 on March 6, 2015 for the ResQCPR system, which pairs the ResQPOD ITD 16 with the ResQPUMP. The approved indication is a CPR adjunct in adult non-traumatic cardiac arrest.
Does an ITD improve survival?
In the 2011 ROC PRIMED trial with standard CPR, survival with satisfactory function was 6.0% with a sham device and 5.8% with the active device (P=0.71). The 2015 Canadian guideline highlights say routine use with conventional CPR is not recommended.
How is an ITD related to other CPR devices?
It is one of several CPR adjuncts. See the guides on the LUCAS device, CPR machines, CPR feedback devices and the crash cart.
Sources
Links checked 2026-11-01.
- FDA, Summary of Safety and Effectiveness Data, PMA P110024 (ResQCPR System): https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110024B.pdf
- openFDA device 510(k) database, ResQPOD records: https://api.fda.gov/device/510k.json?search=device_name:resqpod
- Aufderheide TP et al., A trial of an impedance threshold device in out-of-hospital cardiac arrest, N Engl J Med 2011;365(9):798-806: https://pubmed.ncbi.nlm.nih.gov/21879897/ (doi 10.1056/NEJMoa1010821)
- Heart and Stroke Foundation of Canada, Highlights at a glance, 2015 Guidelines Update for CPR and ECC: https://www.heartandstroke.ca/-/media/pdf-files/canada/cpr-2017/resus-pdf-highlights-at-a-glanceen.ashx







